Awarded

3. Atogepant (N02CD07)

Name: 3. Atogepant (N02CD07)
Creator: Krajská nemocnice T. Bati, a. s.
Published: 2026-10-15
License: https://ted.europa.eu/en/simap/legal-notice

Original language: Czech

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Buyer: Krajská nemocnice T. Bati, a. s.
Winners: AbbVie s.r.o.
Contract value: CZK 774,620
Bids received: 1
Published: 15 Oct 2026
Awarded: 16 Sept 2026
Contract start: 12 Aug 2026
Contract end: 25 Aug 2027estimated
Sector: Medical equipment and pharmaceuticals
Region: Zlínský kraj
Source: Original notice on TED (718560-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
I. Everolimus (ATC L01EG02)	Krajská nemocnice T. Bati, a. s.	Alliance Healthcare s.r.o.	CZK 485,772	26 Oct 2026
IV. Omalizumab (ATC R03DX05)	Krajská nemocnice T. Bati, a. s.	PHOENIX lékárenský velkoobchod, s.r.o.	CZK 1,768,000	26 Oct 2026
III. Nintedanib (ATC L01EX09)	Krajská nemocnice T. Bati, a. s.	PROMEDICA PRAHA GROUP, a.s.	CZK 1,186,842	26 Oct 2026
II. Glatiramer-acetát (ATC L03AX13)	Krajská nemocnice T. Bati, a. s.	PROMEDICA PRAHA GROUP, a.s.	CZK 1,754,043	26 Oct 2026
Dimethyl-fumarát (ATC L04AX07)	Krajská nemocnice T. Bati, a. s.	Alliance Healthcare s.r.o.	CZK 244,559	26 Oct 2026
5. Eptinezumab (N02CD05)	Krajská nemocnice T. Bati, a. s.	PHOENIX lékárenský velkoobchod, s.r.o.	CZK 772,759	15 Oct 2026